Award recordCONTRACT

APO-PHARMA USA, INC.

PIID 36C24519F0634· VHA· 245-NETWORK CONTRACT OFFICE 5 (36C245)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $2,356 net obligations· UEI JDSKMX3AW5M5· FL

Description

PHARMACY ORDER - KIM LOPES

First action · last action
2019-05-16 · 2019-05-16
Transactions
1
First transaction's obligation
$2,356
Base + all options value (sum of deltas)
$2,356
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D40023
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$2,356$0Base award · 2019-05-16 · this action $2,356 · running total $2,356
  • Base2019-05-16+$2,356= $2,356
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-05-16+$2,356$2,356PHARMACY ORDER - KIM LOPES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JDSKMX3AW5M5)

AwardOffice · PSC / listingNet obligationsFY
36C24520F0484245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$50,449FY2020
36C24820F0107248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$14,407FY2020
36C24520F0248245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$53,556FY2020
36C24220F0122242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$17,852FY2020
36C24519F0803245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$44,630FY2019
36C24219F0433242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2019

Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24526N0840TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$19,139FY2026
36C24526N0839TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$38,360FY2026
36C24526N0837QOL MEDICAL LLC245-NETWORK CONTRACT OFFICE 5 (36C245)$16,945FY2026
36C24526N0835TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$34,605FY2026
36C24526N0834GALDERMA LABORATORIES, L.P.245-NETWORK CONTRACT OFFICE 5 (36C245)$16,960FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24519F0634_3600_V797D40023_3600 · retrieved 2026-09-26.